Invex reports success in using exenatide to delay Alzheimers in ‘microtissue’ simulation
Invex Therapeutics (ASX:IXC) has had success simulating the use of Exenatide to…
Invex Therapeutics Ltd (ASX:IXC)
About Invex Therapeutics Ltd
Key Information
IXC In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 20/01/2025 | Price Sensitive PS Invex Receives $0.22m R&D Tax Rebate from UK Government | 183.57KB | 151 |
| 16/12/2024 | Price Sensitive PS Improved Neuronal Cell Survival in 3D Model of Alzheimer's | 277.69KB | 1.5K |
| 26/11/2024 | Results of Meeting | 195.17KB | 269 |
| 26/11/2024 | Chair's Address to Shareholders | 208.73KB | 314 |
| 17/10/2024 | Addendum to Notice of Annual General Meeting | 123.34KB | 344 |
| 14/10/2024 | Letter to Shareholders AGM | 121.57KB | 386 |
| 14/10/2024 | Notice of Annual General Meeting | 243.61KB | 239 |
| 08/10/2024 | Price Sensitive PS Quarterly Activities Report and Appendix 4C | 393.01KB | 433 |